OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
Aubrey L. Miller, Patrick L. Garcia, Tracy L. Gamblin, et al.
Cancer Drug Resistance (2020)
Open Access | Times Cited: 7
Aubrey L. Miller, Patrick L. Garcia, Tracy L. Gamblin, et al.
Cancer Drug Resistance (2020)
Open Access | Times Cited: 7
Showing 7 citing articles:
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
Aubrey L. Miller, Samuel C. Fehling, Rebecca B. Vance, et al.
Cancer Letters (2024) Vol. 592, pp. 216919-216919
Closed Access | Times Cited: 4
Aubrey L. Miller, Samuel C. Fehling, Rebecca B. Vance, et al.
Cancer Letters (2024) Vol. 592, pp. 216919-216919
Closed Access | Times Cited: 4
Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
Aditi Jain, Vikas Bhardwaj
World Journal of Gastroenterology (2021) Vol. 27, Iss. 39, pp. 6527-6550
Open Access | Times Cited: 31
Aditi Jain, Vikas Bhardwaj
World Journal of Gastroenterology (2021) Vol. 27, Iss. 39, pp. 6527-6550
Open Access | Times Cited: 31
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3470-3470
Open Access | Times Cited: 21
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3470-3470
Open Access | Times Cited: 21
A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
Luis Vergara-Gómez, Carolina Bizama, Jun Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7238-7238
Open Access | Times Cited: 4
Luis Vergara-Gómez, Carolina Bizama, Jun Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7238-7238
Open Access | Times Cited: 4
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
Luigi Sapio, Angela Ragone, Annamaria Spina, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 625-36
Open Access | Times Cited: 4
Luigi Sapio, Angela Ragone, Annamaria Spina, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 625-36
Open Access | Times Cited: 4
The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models
Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, et al.
Cancer Drug Resistance (2024)
Open Access
Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, et al.
Cancer Drug Resistance (2024)
Open Access
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote, et al.
Cell Reports Medicine (2024), pp. 101881-101881
Open Access
Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote, et al.
Cell Reports Medicine (2024), pp. 101881-101881
Open Access
